Kyto Biopharma, Inc. Announces Management Changes
Corporation. Simon P. Westbrook has been appointed Chief Financial Officer of the Corporation. Peter Prendergast has resigned as Director of the Corporation.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1 USD | -45.65% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 16.33M | |
+6.59% | 78.74B | |
+0.17% | 63B | |
+4.40% | 46.21B | |
+7.41% | 36B | |
-23.99% | 12.22B | |
+11.38% | 9.91B | |
-25.08% | 8.24B | |
-3.76% | 7.5B | |
+15.48% | 7.47B |